reports
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and ...
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to $9.22Fiscal 2026 outlook provided DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, 2025. Total revenue fro...
STERIS Declares Dividend of $0.57 per share
STERIS Declares Dividend of $0.57 per share DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infectio...
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Fu...
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025 DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, 2025. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing f...
STERIS Announces Financial Results for Fiscal 2025 Third Quarter
STERIS Announces Financial Results for Fiscal 2025 Third Quarter Total revenue from continuing operations increased 6%; constant currency organic revenue grew 6% As reported diluted EPS from continuing operations increased to $1.75; adjusted EPS increased to $2.32Fiscal 2025 outlook updated DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third quarter of fiscal 2025 increased 6% to $1.4 billion...
STERIS Declares Dividend of $0.57 per share
STERIS Declares Dividend of $0.57 per share DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on i...
STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financi...
STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025 DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will...
STERIS Announces Outcome of Ethylene Oxide Trial
STERIS Announces Outcome of Ethylene Oxide Trial DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix Operations, Inc. (“Isomedix”), a subsidiary of the Company, ended in a mistrial on January 17, 2025. The case is pending in the Circuit Court of Cook County, Illinois, and involves claims by an individual plaintiff that ethylene oxide emissions from a sterilization facility in Waukegan, Illinois, caused personal injury. Isomedix owned and opera...
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
STERIS Announces Financial Results for Fiscal 2025 Second Quarter Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7%As reported diluted EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14Fiscal 2025 outlook reiterated DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) -- - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 increased 7% to $1....
STERIS Declares Dividend of $0.57 per share
STERIS Declares Dividend of $0.57 per share DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on...
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financ...
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024 DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results w...
STERIS to Present at the Morgan Stanley Healthcare Conference
STERIS to Present at the Morgan Stanley Healthcare Conference DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on STERIS’s investor relations website at -ir.com. STERIS is a leading global provider of products and services that support pati...
STERIS Announces Financial Results for Fiscal 2025 First Quarter
STERIS Announces Financial Results for Fiscal 2025 First Quarter Total revenue from continuing operations increased 8%; constant currency organic revenue grew 6%As reported EPS from continuing operations increased to $1.41; adjusted EPS increased to $2.03Fiscal 2025 outlook reiterated DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1.3 billion compar...
STERIS Raises Dividend to $0.57 per share
STERIS Raises Dividend to $0.57 per share DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company’s 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com...
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financi...
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024 DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be...
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and ...
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billi...
STERIS Announces Dividend of $0.52 per share
STERIS Announces Dividend of $0.52 per share DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on June 26, 2024, to shareholders of record at the close of business on June 12, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at . STERIS is a leading global provider of products and services that support patient care with an emphasis on infection preve...
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Fu...
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024 DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing ...
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital Transaction expected to close in STERIS’s first quarter of fiscal 2025Divestiture allows STERIS to focus on Customers within core marketsProceeds primarily to be used to repay debt DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) -- ) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million (the “Transaction”). The Transaction is structu...
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
STERIS Announces Financial Results for Fiscal 2024 Third Quarter Third quarter revenue increases 15% as reported; 10% constant currency organicAs reported diluted earnings per share increased to $1.42; adjusted earnings per share increased to $2.22Fiscal 2024 outlook updated DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the third quarter of fisc...
STERIS Announces Dividend of $0.52 per share
STERIS Announces Dividend of $0.52 per share DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at . STERIS is a leading global provider of products and services that support patient care with an emphasis on infection...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.